CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −4,495 | 4,495 | ||
| 2019-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −2,798 | 5,595 | ||
| 2019-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −9,555 | 19,110 | ||
| 2019-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +2,990 | 5,252 | ||
| 2019-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +9,727 | 14,979 | ||
| 2019-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −2,990 | 5,980 | ||
| 2019-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −9,727 | 19,453 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +2,668 | 28,311 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +2,075 | 30,386 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +1,270 | 31,656 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +4,213 | 35,869 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Shares withheld for taxes | −2,501 | $5.51 | $14K | 33,368 |
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −2,668 | 0 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −2,075 | 2,075 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −1,270 | 2,540 | ||
| 2019-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −4,213 | 8,427 | ||
| 2019-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +2,352 | 7,649 | ||
| 2019-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +2,593 | 10,242 | ||
| 2019-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +8,463 | 18,705 | ||
| 2019-02-28 | Santini Alexander A EVP and CCO | Shares withheld for taxes | −4,544 | $5.51 | $25K | 14,161 |
Page 46 of 51 · 1,001 trades